Evidence map›Paper›PMID 25398105›Full record

ArticleAmerican journal of respiratory and critical care medicine2014

MARCKS is marked in combating lung cancer growth and acquired resistance.

Sekhar P Reddy, Viswanathan Natarajan, Arkadiusz Z Dudek

Abstract readEditorialComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Venous endothelial remodeling mediated byFrontiers in immunology · 2026
    Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sekhar P Reddy1 Department of Pediatrics University of Illinois at Chicago Chicago, Illinois.
Viswanathan Natarajan
Arkadiusz Z Dudek

Funding

Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
The Role and Biology of Fra-1 in Lung Injury and RepairR01ES011863 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REDDY, SEKHAR P. · 2002 to 2013
$3.4M
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & DevelopmentR21ES018998 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REDDY, SEKHAR P. · 2011 to 2012
$430k
Fra-1/Nrf2 Balance Signaling and Resolution of Inflammatory Lung InjuryR56ES011863 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REDDY, SEKHAR P. · 2016 to 2016
$90k
NHLBI NIH HHS P01 HL098050NIEHS NIH HHS R01 ES011863NIEHS NIH HHS R21 ES018998NIEHS NIH HHS R56 ES011863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHumansIntracellular Signaling Peptides and ProteinsLung NeoplasmsMembrane ProteinsMyristoylated Alanine-Rich C Kinase SubstrateIntracellular Signaling Peptides and ProteinsMARCKS protein, humanMembrane ProteinsMyristoylated Alanine-Rich C Kinase Substrate

Identifiers

PMID25398105
PMCPMC4299642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.